250 Mg Abiraterone Acetate Tablets

Name: 250 Mg Abiraterone Acetate Tablets
Brand: NEETCO BIOPHARMA
Price: 4499 INR
Availability: InStock

Price 4499 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

250 Mg Abiraterone Acetate Tablets Specification

Dosage Form
Tablet

Indication
Treatment of metastatic castration-resistant prostate cancer

Salt Composition
Abiraterone Acetate 250 mg

Feature
Prescription medicine for oral administration

Ingredients
Abiraterone Acetate and excipients

Application
Oncology, Cancer Therapy

Physical Color/Texture
White to off-white, oval, film-coated tablet

Fermentation Smell
Odorless

Storage Instructions
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C

Shelf Life
24 months

Prescription/Non-prescription
Prescription Only

Caution
Monitor liver function and potassium levels during therapy

Regulatory Status
WHO-GMP/Approved by National Regulatory Authority

Patient Population
Adult males with prostate cancer

Tablet Size
Standard oval tablet approximately 16 mm length

Packaging Type
Box containing blister strips

Marketed By
Leading pharmaceutical distributor

Contraindications
Hypersensitivity to Abiraterone or excipients; severe hepatic impairment

Administration Route
Oral

Common Side Effects
Hypertension, hypokalemia, fluid retention, liver function abnormalities

Warning
To be used under medical supervision only. Not for use in women or children.

Primary Function
CYP17 enzyme inhibitor for androgen biosynthesis suppression

Strength
250 mg per tablet

About 250 Mg Abiraterone Acetate Tablets

Last Chance to find a brilliant solution for metastatic castration-resistant prostate cancer with 250 mg Abiraterone Acetate Tablets. Scarce in availability, this pivotal therapy is valorous in suppressing androgen biosynthesis by inhibiting the CYP17 enzyme. Each standard oval tablet (16 mm) is packaged in a box with blister strips and is designed exclusively for oral administration under prescription. Marketed by a leading distributor in India, these tablets meet WHO-GMP standards and regulatory approval. For adult males only, not for women or children. Medical supervision is mandatory.

Exceptional Usage & Applications in Oncology

250 Mg Abiraterone Acetate Tablets are used in cancer therapy, specifically for the treatment of metastatic castration-resistant prostate cancer in adult males. With a pivotal role as a CYP17 enzyme inhibitor, these tablets are renowned in commercial oncology applications. Their primary competitive advantage lies in exceptional regulatory approval, superior efficacy, and standardized packaging, ensuring reliable supply for hospitals, clinics, and pharmacies.

Impressive Certifications & Delivery Proposal

Certified by WHO-GMP and approved by the National Regulatory Authority, 250 Mg Abiraterone Acetate Tablets come in secure blister strip packaging. Proposal amounts can be tailored to meet various supply requirements, with an estimated delivery time that ensures timely distribution across locations. Shelf life is 24 months, preserving potency. Consistent supply abilities are maintained for bulk and export orders.

FAQ's of 250 Mg Abiraterone Acetate Tablets:

Q: How should 250 Mg Abiraterone Acetate Tablets be administered for optimal benefit?

A: These tablets are intended for oral administration in adult males under strict medical supervision. It is vital to follow the prescribed dosage and monitor liver function and potassium levels during therapy to maximize safety and efficacy.

Q: What is the primary function of Abiraterone Acetate 250 mg in cancer therapy?

A: Abiraterone Acetate acts as a CYP17 enzyme inhibitor, suppressing androgen biosynthesis, which is a pivotal step in treating metastatic castration-resistant prostate cancer.

Q: When is Abiraterone Acetate contraindicated for use?

A: Abiraterone Acetate should not be used in individuals with hypersensitivity to its ingredients or excipients and those with severe hepatic impairment.

Q: Where is 250 Mg Abiraterone Acetate Tablets manufactured and distributed?

A: These tablets are marketed and distributed by a leading pharmaceutical supplier in India, compliant with WHO-GMP certification and National Regulatory Authority approval.

Q: What precautions are necessary during therapy with Abiraterone Acetate?

A: Patients should have liver function and potassium levels assessed regularly. Additionally, this medication is only for adult males, not intended for use by women or children.

Tell us about your requirement